📋DEA Notice
Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More📜OFAC Sanctions Notice
The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) is publishing the names of one or more persons that have been placed on OFAC's Specially Designated Nationals and Blocked Persons List (SDN List) based on OFAC's determination that one or more applicable legal criteria were satisfied. All property and interests in property subject to U.S. jurisdiction of this person are blocked, and U.S. persons are generally prohibited from engaging in transactions with this person.
Learn More🏛️Regulatory Freeze Memorandum
The memorandum orders a freeze on regulatory actions, requiring reviews and approvals of rules by newly appointed agency heads. It emphasizes compliance with existing Executive Orders and highlights the need for a careful review process for any pending regulations, ultimately impacting the operational landscape for businesses.
Learn More⚡Army Proposes Environmental Upgrades at Fort Wainwright, Alaska
The Department of the Army (Army) is supplementing the Final Environmental Impact Statement (Final EIS) addressing heat and electrical upgrades at Fort Wainwright, Alaska. The current coal-fired central heat and power plant (CHPP) and its aging heat distribution system require an upgrade that resolves safety, resiliency, fiscal, and regulatory concerns. After publication of the Final EIS Notice of Availability (NOA) in the Federal Register on February 10, 2023, the Army determined that additional analysis is required prior to the Army executing a Record of Decision.
Learn More🏦CFPB Consumer Advisory Board Meeting Notice and Implications for Businesses
Under the Federal Advisory Committee Act (FACA), this notice sets forth the announcement of a public meeting of the Consumer Advisory Board (CAB or Board) of the Consumer Financial Protection Bureau (CFPB). The notice also describes the functions of the Board.
Learn More📜FDA Delays Effective Date for Nonprescription Drug Regulation
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Learn More